Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015

Introduction Despite the clinical, epidemiological, and economic significance of metabolic syndrome, the profile of clinical trials on this disease is unknown. Objective To characterize the clinical trials related to treatment of metabolic syndrome during the 1980-2015 period. Methods Systematic review of the literature using an ex ante search protocol which followed the phases of the guide Preferred Reporting Items for Systematic Reviews and Meta-Analyses in four multidisciplinary databases with seven search strategies. Reproducibility and methodological quality of the studies were assessed. Results One hundred and six trials were included, most from the United States, Italy, and Spain, of which 63.2% evaluated interventions effective for several components of the syndrome such as diet (40.6%) or physical activity (22.6%). Other studies assessed drugs for a single factor such as hypertension (7.5%), hypertriglyceridemia (11.3%), or hyperglycemia (9.4%). Placebo was used as control in 54.7% of trials, and outcome measures included triglycerides (52.8%), HDL (48.1%), glucose (29.2%), BMI (33.0%), blood pressure (27.4%), waist circumference (26.4%), glycated hemoglobin (11.3%), and hip circumference (7.5%). Conclusion It was shown that studies ob efficacy of treatment for metabolic syndrome are scarce and have mainly been conducted in the last five years and in high-income countries. Trials on interventions that affect three or more factors and assess several outcome measures are few, and lifestyle interventions (diet and physical activity) are highlighted as most important to impact on this multifactorial syndrome. © 2017 SEEN

• Autores: Cardona Velásquez S.; Guzmán Vivares L.; Cardona Arias, Jaiberth antonio
• Tipo de recurso: Article of journal
• Fecha de publicación: 2023
• Institución: Universidad Cooperativa de Colombia
• Repositorio: Repositorio UCC
• OAI Identifier: oai:repository.ucc.edu.co:20.500.12494/49522
• Acceso en línea: https://doi.org/10.1016/j.endinu.2016.09.002; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017344913&doi=10.1016%2fj.endinu.2016.09.002&partnerID=40&md5=d4f8e19abb348240c7072f2af42f5a09; https://hdl.handle.net/20.500.12494/49522
• Palabra clave: ARTICLE; BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL (TOPIC); DIET; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HIP CIRCUMFERENCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ITALY; METABOLIC SYNDROME X; METHODOLOGY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PLACEBO; REPRODUCIBILITY; SPAIN; SYSTEMATIC REVIEW; TRIACYLGLYCEROL; UNITED STATES; WAIST CIRCUMFERENCE
• Rights: openAccess
• License: http://purl.org/coar/access_right/c_abf2